Robin Wojcieszek

Robin Wojcieszek is an accomplished professional with extensive experience in regulatory affairs and drug safety, currently serving as Senior Vice President of Regulatory Affairs and Drug Safety at QurAlis. Previously, Robin held the position of Vice President and Global Head of Safety & Pharmacovigilance at FibroGen, Inc., and served as Vice President of Regulatory Affairs in the US for Lundbeck. Additionally, Robin contributed as Senior Director at Eli Lilly and Company and is a member of The Critical Path Institute - CAMD.